APAM: Alternating Pressure Air Mattress and Pressure Injury Prevalence

Sponsor
National Taiwan University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT06151327
Collaborator
(none)
50,419
1
12
127885.7

Study Details

Study Description

Brief Summary

explore the correlation of accurate implementation of APAM and pressure injury prevalence

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    50419 participants
    Observational Model:
    Other
    Time Perspective:
    Retrospective
    Official Title:
    Explore the Relationship Between Implementation of Alternating Pressure Air Mattress and Pressure Injury Prevalence
    Actual Study Start Date :
    Oct 20, 2023
    Actual Primary Completion Date :
    Oct 31, 2023
    Actual Study Completion Date :
    Nov 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. proportion of full thickness pressure injury [2020/1 ~2023/8]

      total number of full thickness pressure injuries devided by total number of pressure injuries

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    patients with pressure injury

    Exclusion Criteria:

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 National Taiwan Universiyt Hospital Yunlin Branch Douliu Yunlin Taiwan

    Sponsors and Collaborators

    • National Taiwan University Hospital

    Investigators

    • Principal Investigator: Hui-Hsiu Chang, National Taiwan University Hospital Yunlin brach

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    National Taiwan University Hospital
    ClinicalTrials.gov Identifier:
    NCT06151327
    Other Study ID Numbers:
    • 202309095RINA
    First Posted:
    Nov 30, 2023
    Last Update Posted:
    Nov 30, 2023
    Last Verified:
    Nov 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 30, 2023